Purpose: To investigate the effect of gum chewing on the cognitive function of attention. Methods: Based on gum chewing habit, trait-anxiety variable, and different treatments(with or without gum chewing) during experiment,181 college students with good health were assigned to four groups GH (with chewing gum treatment and habit), GL (with chewing gum treatment, no habit), CH (no treatment,has habit) and CL (no treatment,no habit). Two attention tasks: Continuous Performance Test (CPT-AX) and Conjunctive Search Task (CST) were performed by all subjects in the laboratory.Results: Chewing gum during experiment had positive effect on attention performance, and the habit of gum chewing played an important role. Conclusion: Gum chewing had positive effect on attention performance, suggesting the effects mainly came from the familiarity of gum-chewing.

Objective To discuss the clinical effect of aspirin combined with clopidogrel therapy in pa?tients with transient ischemic attack( TIA)/light stroke. Methods One hundred and forty?eight cases with tran?sient ischemic attack/light stroke were divided randomly and voluntarily into the control group( n=74) and ob?servation group( n=74) . The patients of the control group were given aspirin based on conventional treatment while the observation group were given clopidogrel based on control group treatment. The serum C?reactive pro?tein(CRP),incidence of early neurologic deterioration(END),recurrence rate within 90 days,degree of nerve function defect score (NIHSS score),clinical effect after treatment and the complications during treatment be?tween the two groups were compared. Results After one week treatment,the serum CRP level of observation group decreased obviously compared with pre?treatment ( ( 6. 24 ± 1. 63 ) mg/L vs. ( 12. 03 ± 2. 46 ) mg/L , t=5. 625,P=0. 027),and the control group((9. 34±1. 24) mg/L,t=4. 348,P=0. 036),and there was not sig?nificantly reduced in the control group( t=2. 647,P=0. 186) . The incidence of END and recurrence rate within 90 days of observation group were evidently lower than that of control group(6. 76%(5/74) vs. 21. 62%(16/74) ,1. 35%( 1/74) vs. 8. 12%( 6/74);χ2=6. 737,5. 742,P=0. 022,0. 029) . The NIHSS score at 2 weeks af?ter treatment of observation group evidently lower than that of control group,the differences were statistically sig?nificant((2. 31±1. 03) points vs. (5. 34±1. 25) points;t=4. 663,4. 928). The effective rate of observation group was obviously higher than that of control group,the differences were statistically significant(93. 24% vs. 63. 51%,χ2=6. 253,P=0. 029) . There was no statistically significant differences about complications during treatment in both groups. Conclusion Aspirin combined with clopidogrel therapy can obviously improve nerve function,reduce progress of stroke and improve the clinical effect in patients with transient ischemic attack/light stroke,it is worth popularization and application.

Objective To discuss the clinical significance of change of serum uric acid (UA),C-reactive protein(CRP) and fibrinogen(Fg) levels in patients with acute cerebral infarction.Methods Ninetysix patients with acute cerebral infarction were divided into the mild group (n =52),middle group(n =32) and heavy group(n =12) according to illness degree,and 90 healthy person were selected as the control group.The serum UA,CRP and Fg of all groups were compared.Correlation analysis of serum UA,Fg and CRP in patients with acute cerebral infarction was carried.Results The level of serum UA((423.6±46.5) μmol/L vs.(302.4±28.7) μmol/L,t=4.758,P＜0.05),CRP((15.6±2.3) mg/L vs.(1.9±0.8) mg/L,t =14.547,P＜0.05) and Fg((4.6± 1.4) g/L vs.(3.1 ±0.9) g/L,t =3.936,P＜ 0.05) of acute cerebral infarction group were all obviously higher than that of control group,the differences were statistically significant(P＜0.05).The levels of serum UA((366.2±23.5) μmol/L,(398.4± 32.7) μmol/L and (457.4± 56.2) μmol/L,F =7.646),CRP ((7.4±1.6) mg/L,(14.6±1.9) mg/L and (22.8±4.6) mg/L,F=9.837) and Fg((3.3±1.4) g/L,(3.9 ± 1.5) g/L and (5.2 ± 2.1) g/L,F =5.757) of mild,middle and heavy groups rise with illness degree,differences were all statistically significance(P＜0.05).Correlation analysis showed that serum UA,CRP levels and Fg,CRP were positively correlated (r =0.683,0.564),the differences were statistically significant (P ＜0.05).Conclusion Serum UA,CRP and Fg levels in patients with acute cerebral infarction obviously increase and they can be regarded as to predict risk factors of cerebral infarction.

Objective To analyze influence of atorvastatin calcium on blood lipid and high-sensitivity C-reactive protein (hs-CRP) in patients with acute cerebral infarction.Methods One hundred and forty patients with acute cerebral infarction were randomly divided into the control group (n =70) and observation group(n =70).Patients in the control group were given simvastatin calcium,and in the observation group were given calcium beside control therapy scheme.The course was four weeks.The serum levels of blood lipid and hsCRP of before and one week and four weeks after treatment were measured and compared between the two groups.Results The total cholesterol(TC),glycerin trilaurate(TG) level and low density lipoprotein cholesterol (LDL-C) in control group before and after treatment were (6.4± 1.6) mmol/L and (6.4± 1.6) mmol/L,(3.3±0.6) mmol/L and (2.2±0.5) mmol/L,(4.7±0.8) mmol/L and (3.3±0.6) mmol/L,and the difference was significant (t=7.364,5.872,5.692;P=0.028,0.042,0.035).The TC,TG levels,LDL-C in observation group before and after treatment were (6.4±1.4) mmol/L and (3.5±0.6) mmol/L,(3.2±0.8) mmol/L and (1.8±0.5) mmol/L,(4.6±0.6) mmol/L and (2.4±0.5) mmol/L,and the differences were significant (t =8.657,6.264,6.674;P =0.015,0.029,0.043).Meanwhile,observation group decreased more significantly (t =4.264,4.827,4.874;P＜0.05).The HDL-C in control group before and after treatment were (1.3±0.4) mmol/L and (1.6± 0.7) mmol/L,in observation group were (1.2 ± 0.5) mmol/L and (2.4 ± 0.5) mmol/L,and the differences were significant (t =5.976,6.743;P =0.039,0.031).Meanwhile,observation group increased more significantly(t =5.363,P＜ 0.05).The hs-CRP of all groups significantly reduced after treatment,and the differences were statistically significant,and the degree of decline was more significant in observation group (treatment effects and time effects of the F values were 24.565 and 15.675,P ＜ 0.05).Conclusion Atorvastatin calcium can effectively reduce the blood lipid and hs-CRP of patients with acute cerebral infarction and the incidence of cerebrovascular disease,and it is worth popularization and application.

Objective To summarize the neuropsychic manifestations of thallium poisoning to attract attention of neuropsychiatrists. Methods Eight cases of thallium poisoning were reported. The manifestations of thallium poisoning and the relative literatures were reviewed. We discussed the relationship between mechanism of thallium poisoning and nervous system,neuropsychic manifestation and pathology of thallium poisoning. Results Three of 8 cases were acute and severe,presenting bellyache,nausea,vomit, fantod,delirium,coma,convulsion,respiratory failure,low blood pressure and tachycardia. They all died in a short period. The other 5 cases were subacute or chronic. Most of them manifested the impairment of central nervous system,peripheral nerve and optic nerve. Some of them had alopecia.Six of 8 cases were misdiagnosed as other neurological diseases. Two were suspicious of thallium poisoning,but failed to be diagnosed for the time being. The 5 survivors of 8 cases obviously restored after heteropathy. Few cases had neurologic sequelae. Conclusions For lacking of contact history, it is difficult to diagnose thallium poisoning caused by malicious contamination or accidental poisoning. Attention should be paid to those patients with indefinite damage of peripheral and central nervous system. When alopecia appears,thallium poisoning must be suspicious of. For the suspected cases,it is necessary to measure the thallium level in blood and urine in order to verify the diagnosis.

Bronchopulmonary dysplasia (BPD) is a chronic pulmonary disease which seriously affects the survival and long term quality of life in premature infants. Its pathogenesis is not yet clear. In recent years, the role of pulmonary vascular dysplasia in BPD has received increasing attention and evolved into a“vascular hypothesis”of the pathogenesis of BPD. Angiogenesis therapy based on this hypothesis has also made some progress in the treatment of BPD. This paper brielfy reviews the current research situation in this ifeld.

Naloxone is a synthetic pan-opioid receptor competitive antagonist of the opioid receptors inside and outside the cen-tral nervous system. After systemic administration, it reverses almost all opioid effects. Systemically administered naloxone is used to reverse the life-threatening opioid toxicity. A number of studies have analyzed the importance of oral naloxone as a peripheral opioid an-tagonist in cancer patients. Naloxone has shown satisfactory efficacy for opioid-induced constipation (OIC). Ultra-low dose of naloxone has been reported to enhance the anti-nociceptive effect of morphine and reduce morphine consumption. We summarize the results from current studies of naloxone administration in cancer pain management.

Objective: To analyze the clinical characteristics of opioid overdose in naloxone-antagonized advanced cancer pa-tients. Methods:Fifteen patients with moderate to severe cancer pain were diagnosed with opioid overdose. Five of the patients were treated with transdermal fentanyl, six with prolonged-release morphine sulfate tablets, and four with prolonged-release oxycodone hy-drochloride tablets. Naloxone was immediately administered upon discovery of opioid overdose. The reasons behind opioid overdose as well as the naloxone efficacy and patient prognosis were investigated. Results:In the patients of the group, the equivalent dosage of morphine, the treatment dosage is 10 mg/d to 640 mg/d, and the median dosage is 360 mg/d. The therapeutic dose of naloxone is 0.2 mg to 0.8 mg, and the median dosage is 0.4 mg. After naloxone use, the pupils of the patients were recovered in the first few min-utes, and respiratory depression improved within 10 min to 30 min. However, blood pressure recovery was slow for at least 1 hour. Two fever-afflicted patients were diagnosed with transdermal fentanyl overdose and impaired liver function, which exhibited rapid deteriora-tion immediately before the opioid overdose. Seven patients with poor pain control were diagnosed with opioid overdose during drug ti-tration. These patients were given poor prognosis, and their median overall survival time was 1.9 months. Conclusion: Opioid over-dose, which is shown to be common in advanced cancer patients, can be safely and effectively treated by naloxone. Early diagnosis and treatment of this condition would significantly improve the quality of pain control for the patient.

Objective To explore the effect of recombinant bovine basic fibroblast growth factor(rb-bFGF)combined with boric acid solution on vulval ulcer.Methods 64 patients with vulval ulcer were divided into two groupa randomly.33 patients( group A) with vulval ulcer was treated with rb-bFGF and boric acid solution locally,while the others (group B) accepted ultra-red rays.Before the different treatment above,metronidazole or clotrimasole was put into the vaginae of all the patients,which were given relative medicine according to etiopathogenesis.The two groups were treated continually for two weeks and then were examined.Results The effective rate in group A was significantly higher than that in group B,which was the same result as the ulcer heating time between two groups.Conclusion rb-bGFG combined with boric acid solution is an effective remedy for the treatment of vulval ulcer.

Opioid-induced constipation (OIC) is the most common side effect of opioid. OIC influences the quality of life of pa-tients suffering from cancer pain. However, given that the drug is often overlooked and underappreciated, most of the time, the patients would avoid or abandon using opioid and, as a result, they continuously suffer from cancer pain. Therefore, OIC prevention and man-agement must be made before opioid use. The consensus on the diagnosis of OIC has only been reached recently. Thus, a unified defini-tion of OIC must be developed to exchange therapeutic option among departments in hospitals and compare treatment outcome. The di-agnosis of OIC is discussed, and the management of OIC, including medicinal and non-medicinal treatment, is summarized. Mean-while, the initial program for prevention and treatment of OIC is established to make OIC management more convenient for clinical physicians. Much work is still needed to establish a consensus on OIC diagnosis and a suitable program for prevention and treatment of OIC.